Detailed Information on Publication Record
2019
The clinical benefit of array-based comparative genomic hybridization for detection of copy number variants in Czech children with intellectual disability and developmental delay
WAYHELOVÁ, Markéta, Jan SMETANA, Vladimíra VALLOVÁ, Eva HLADÍLKOVÁ, Hana FILKOVÁ et. al.Basic information
Original name
The clinical benefit of array-based comparative genomic hybridization for detection of copy number variants in Czech children with intellectual disability and developmental delay
Authors
WAYHELOVÁ, Markéta (203 Czech Republic, belonging to the institution), Jan SMETANA (203 Czech Republic, belonging to the institution), Vladimíra VALLOVÁ (703 Slovakia, belonging to the institution), Eva HLADÍLKOVÁ (203 Czech Republic), Hana FILKOVÁ (203 Czech Republic), Marta HANÁKOVÁ (203 Czech Republic), Marcela VILÉMOVÁ (203 Czech Republic), Petra NIKOLOVÁ (203 Czech Republic), Barbora GROMESOVÁ (203 Czech Republic), Renata GAILLYOVÁ (203 Czech Republic) and Petr KUGLÍK (203 Czech Republic, guarantor, belonging to the institution)
Edition
BMC MEDICAL GENOMICS, LONDON, BIOMED CENTRAL LTD, 2019, 1755-8794
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
10603 Genetics and heredity
Country of publisher
United Kingdom of Great Britain and Northern Ireland
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 2.570
RIV identification code
RIV/00216224:14310/19:00110250
Organization unit
Faculty of Science
UT WoS
000477034800001
Keywords in English
intellectual disability; developmental delay; microdeletion; microduplication; CNV; array CGH
Tags
Tags
International impact, Reviewed
Změněno: 23/3/2020 13:24, Mgr. Marie Šípková, DiS.
Abstract
V originále
Chromosomal microarray analysis has been shown to be a valuable and cost effective assay for elucidating copy number variants (CNVs) in children with intellectual disability and developmental delay (ID/DD). In our study, we performed array-based comparative genomic hybridization (array-CGH) analysis using oligonucleotide-based platforms in 542 Czech patients with ID/DD, autism spectrum disorders and multiple congenital abnormalities. Prior to the array-CGH analysis, all the patients were first examined karyotypically using G-banding. The presence of CNVs and their putative derivation was confirmed using fluorescence in situ hybridization (FISH), multiplex ligation-dependent probe amplification (MLPA) and predominantly relative quantitative polymerase chain reaction (qPCR). In total, 5.9% (32/542) patients were positive for karyotypic abnormalities. Pathogenic/likely pathogenic CNVs were identified in 17.7% of them (96/542), variants of uncertain significance (VOUS) were detected in 4.8% (26/542) and likely benign CNVs in 9.2% of cases (50/542). We identified 6.6% (36/542) patients with known recurrent microdeletion (24 cases) and microduplication (12 cases) syndromes, as well as 4.8% (26/542) patients with non-recurrent rare microdeletions (21 cases) and microduplications (5 cases). In the group of patients with submicroscopic pathogenic/likely pathogenic CNVs (13.3%; 68/510) we identified 91.2% (62/68) patients with one CNV, 5.9% (4/68) patients with two likely independent CNVs and 2.9% (2/68) patients with two CNVs resulting from cryptic unbalanced translocations. Of all detected CNVs, 21% (31/147) had a de novo origin, 51% (75/147) were inherited and 28% (41/147) of unknown origin. Our results confirm the benefit of array-CGH in the current clinical genetic diagnostics leading to identification of the genetic cause of ID/DD in affected children.
Links
MUNI/A/0958/2018, interní kód MU |
|